
The tumor is out, and the hole is bigger than you'd expect. During my surgical residency, I was at the table for dozens of mouth cancer operations. When the cancer reaches the jaw, surgeons rebuild it from the fibula, the thin bone in the lower leg. Most of those patients smoked. Years later, I put a nicotine pouch under my own lip to see if it would sharpen my focus. Fifteen minutes later, I was in the bathroom.
This episode looks at where the nicotine went: into vapes, into pouches, into the office fridge. It starts on the maxillofacial ward, with the pattern we called the deadly triad, and with an uncomfortable fact: doctors know exactly where smoking leads, and plenty of them still smoke. I call that information loses to incentives. A cigarette pays out within minutes. The bill comes twenty or thirty years later.
Then the numbers that matter. In a pooled analysis of 17 studies with more than 11,000 head and neck cancer patients, heavy smoking plus heavy drinking came to about 14 times the odds of these cancers, compared with people who did neither. The good news is just as clear: quitting before 40 was linked to avoiding about 90% of the extra risk of dying early that smoking adds, and quitting in your 40s still avoided most of it.
Among US 18- to 24-year-olds, 14.8% vaped in 2024 and only 3.4% smoked. For a smoker, the evidence is on the vape's side: across 11 trials, about 4 more people in every 100 quit with a vape than with patches or gum. For someone who never smoked, none of that applies.
The episode closes with a check of ZYN's new FDA-authorized claim, my verdicts on each nicotine product, and three things you can do this week.
In this episode:
- The deadly triad: smoking, drinking, and a mouth nobody looked after.
- Information loses to incentives: why doctors who know still smoke.
- Smoking plus drinking: about 14 times the odds of head and neck cancer.
- Quit before 40, and most of the extra risk is gone. The mouth recovers too.
- Why teenagers pick flavored vapes over cigarettes.
- For a smoker, a vape is the best exit, with two catches.
- Heated tobacco and the trials funded by tobacco companies.
- The pouch I tried once, and the mechanism trap behind nicotine for focus.
- ZYN's new claim and the comparison in the fine print.
[Visit The Upward ARC and subscribe](https://www.andreheeg.com).
Under Load is the Sunday edition of The Upward ARC, by Andre Heeg, MD, DDS, doctor and dentist, trained in facial surgery. This edition sits within the Capacity pillar: what you can still do at 70, from thinking clearly to eating and talking without effort.
This episode is general health education, not individual medical advice. If you want to stop smoking, vaping or using nicotine, talk to your doctor.
### Key sources
- [Gioino (Fortune), 2026](https://fortune.com/2026/03/04/palantir-tech-companies-offices-vending-machines-tobacco-worker-productivity/): Palantir and other tech companies are stocking offices with nicotine products to increase worker productivity.
- [Hashibe et al., 2009](https://doi.org/10.1158/1055-9965.EPI-08-0347): Interaction between tobacco and alcohol use and the risk of head and neck cancer.
- [Cho et al., 2024](https://doi.org/10.1056/EVIDoa2300272): Smoking cessation and short- and longer-term mortality.
- [Marron et al., 2010](https://doi.org/10.1093/ije/dyp291): Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk.
- [Agaku, 2026](https://doi.org/10.1056/EVIDpha2500339): Tobacco product use among U.S. adults, 2023–2024.
- [Park-Lee et al., 2026](https://doi.org/10.1093/ntr/ntag116): Tobacco product use among middle and high school students in the United States: National Youth Tobacco Survey, 2025.
- [U.S. Department of Health and Human Services, 2016](https://www.ncbi.nlm.nih.gov/books/NBK538680/): E-cigarette use among youth and young adults: A report of the Surgeon General.
- [Lindson et al., 2026](https://doi.org/10.1002/14651858.CD010216.pub11): Electronic cigarettes for smoking cessation (Cochrane).
- [Hajek et al., 2019](https://doi.org/10.1056/NEJMoa1808779): A randomized trial of e-cigarettes versus nicotine-replacement therapy.
- [Goniewicz et al., 2018](https://doi.org/10.1001/jamanetworkopen.2018.5937): Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes.
- [Tattan-Birch et al., 2022](https://doi.org/10.1002/14651858.CD013790.pub2): Heated tobacco products for smoking cessation and reducing smoking prevalence (Cochrane).
- [Heishman et al., 2010](https://doi.org/10.1007/s00213-010-1848-1): Meta-analysis of the acute effects of nicotine and smoking on human performance.
- [Mallock et al., 2024](https://doi.org/10.1136/tc-2022-057280): Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches.
- [U.S. Food and Drug Administration, 2026](https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-20-zyn-nicotine-pouches-be-marketed-specific-modified-risk-claim): FDA authorizes 20 ZYN nicotine pouches to be marketed with specific modified risk claim.
- [National Health Service, n.d.](https://www.nhs.uk/conditions/mouth-cancer/symptoms/): Mouth cancer: Symptoms.
### Audio note
The recording is the written edition adjusted for listening. Some figures are rounded, and citations are left out. Every study is referenced in the written edition at andreheeg.com.
Weitere Episoden von „Under Load“



Verpasse keine Episode von “Under Load” und abonniere ihn in der kostenlosen GetPodcast App.








